TCT-625 Five-Year Clinical Outcomes of NOBORI Biolimus-Eluting Stent versus XIENCE Everolimus-Eluting Stent in Diabetic Patients

Yuichi Tanaka,Shoichi Kuramitsu,Takashi Hiromasa,Makoto Hyodo,Shinichi Shirai,Kenji Ando

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY（2018）

引用 0|浏览9

暂无评分

摘要

Diabetes mellitus remains a significant predictor of adverse clinical outcomes even in the newer-generation drug-eluting stent (DES) era. However, long-term clinical outcomes of various DES in diabetic patients have not yet been fully evaluated. We sought to compare long-term clinical outcomes

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要